241 related articles for article (PubMed ID: 37517692)
1. Allosteric modulation of cytochrome P450 enzymes by the NADPH cytochrome P450 reductase FMN-containing domain.
Burris-Hiday SD; Scott EE
J Biol Chem; 2023 Sep; 299(9):105112. PubMed ID: 37517692
[TBL] [Abstract][Full Text] [Related]
2. Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains.
Smith GC; Tew DG; Wolf CR
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8710-4. PubMed ID: 8078947
[TBL] [Abstract][Full Text] [Related]
3. Critical residues involved in FMN binding and catalytic activity in cytochrome P450BM-3.
Klein ML; Fulco AJ
J Biol Chem; 1993 Apr; 268(10):7553-61. PubMed ID: 8463285
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 17A1 Interactions with the FMN Domain of Its Reductase as Characterized by NMR.
Estrada DF; Laurence JS; Scott EE
J Biol Chem; 2016 Feb; 291(8):3990-4003. PubMed ID: 26719338
[TBL] [Abstract][Full Text] [Related]
5. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
6. The interaction of NADPH-P450 reductase with P450: an electrochemical study of the role of the flavin mononucleotide-binding domain.
Estabrook RW; Shet MS; Fisher CW; Jenkins CM; Waterman MR
Arch Biochem Biophys; 1996 Sep; 333(1):308-15. PubMed ID: 8806785
[TBL] [Abstract][Full Text] [Related]
7. Determination of the redox properties of human NADPH-cytochrome P450 reductase.
Munro AW; Noble MA; Robledo L; Daff SN; Chapman SK
Biochemistry; 2001 Feb; 40(7):1956-63. PubMed ID: 11329262
[TBL] [Abstract][Full Text] [Related]
8. Effect of the Insertion of a Glycine Residue into the Loop Spanning Residues 536-541 on the Semiquinone State and Redox Properties of the Flavin Mononucleotide-Binding Domain of Flavocytochrome P450BM-3 from Bacillus megaterium.
Chen HC; Swenson RP
Biochemistry; 2008 Dec; 47(52):13788-99. PubMed ID: 19055322
[TBL] [Abstract][Full Text] [Related]
9. The effects of cytochrome b5, NADPH-P450 reductase, and lipid on the rate of 6 beta-hydroxylation of testosterone as catalyzed by a human P450 3A4 fusion protein.
Shet MS; Faulkner KM; Holmans PL; Fisher CW; Estabrook RW
Arch Biochem Biophys; 1995 Apr; 318(2):314-21. PubMed ID: 7733659
[TBL] [Abstract][Full Text] [Related]
10. SPR-Based study of affinity of cytochrome P450s / redox partners interactions modulated by steroidal substrates.
Ershov PV; Yablokov ЕO; Florinskaya AV; Mezentsev YV; Kaluzhskiy LА; Tumilovich AM; Gilep АА; Usanov SA; Ivanov АS
J Steroid Biochem Mol Biol; 2019 Mar; 187():124-129. PubMed ID: 30468857
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of the re-face loop spanning residues 536-541 and its interactions with the cofactor in the flavin mononucleotide-binding domain of flavocytochrome P450 from Bacillus megaterium.
Kasim M; Chen HC; Swenson RP
Biochemistry; 2009 Jun; 48(23):5131-41. PubMed ID: 19432415
[TBL] [Abstract][Full Text] [Related]
12. Structure of a cytochrome P450-redox partner electron-transfer complex.
Sevrioukova IF; Li H; Zhang H; Peterson JA; Poulos TL
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1863-8. PubMed ID: 10051560
[TBL] [Abstract][Full Text] [Related]
13. The FMN-binding domain of cytochrome P450BM-3: resolution, reconstitution, and flavin analogue substitution.
Haines DC; Sevrioukova IF; Peterson JA
Biochemistry; 2000 Aug; 39(31):9419-29. PubMed ID: 10924137
[TBL] [Abstract][Full Text] [Related]
14. Cryo-EM reveals the architecture of the dimeric cytochrome P450 CYP102A1 enzyme and conformational changes required for redox partner recognition.
Su M; Chakraborty S; Osawa Y; Zhang H
J Biol Chem; 2020 Feb; 295(6):1637-1645. PubMed ID: 31901079
[TBL] [Abstract][Full Text] [Related]
15. Flavin supported fatty acid oxidation by the heme domain of Bacillus megaterium cytochrome P450BM-3.
Gonvindaraj S; Li H; Poulos TL
Biochem Biophys Res Commun; 1994 Sep; 203(3):1745-9. PubMed ID: 7945324
[TBL] [Abstract][Full Text] [Related]
16. Flavin-binding and protein structural integrity studies on NADPH-cytochrome P450 reductase are consistent with the presence of distinct domains.
Narayanasami R; Horowitz PM; Masters BS
Arch Biochem Biophys; 1995 Jan; 316(1):267-74. PubMed ID: 7840627
[TBL] [Abstract][Full Text] [Related]
17. Semi-artificial hydroxylating enzymes created by flavins binding to cytochrome P450 2B4 and by bleomycin binding to NADPH-cytochrome P450 reductase.
Uvarov VYu ; Shumyantseva VV; Bykhovskaya EA; Kolyada LN; Archakov AI
Biochem Biophys Res Commun; 1994 Apr; 200(2):722-5. PubMed ID: 7513993
[TBL] [Abstract][Full Text] [Related]
18. Role of the conserved phenylalanine 181 of NADPH-cytochrome P450 oxidoreductase in FMN binding and catalytic activity.
Paine MJ; Ayivor S; Munro A; Tsan P; Lian LY; Roberts GC; Wolf CR
Biochemistry; 2001 Nov; 40(45):13439-47. PubMed ID: 11695890
[TBL] [Abstract][Full Text] [Related]
19. Mutants of Cytochrome P450 Reductase Lacking Either Gly-141 or Gly-143 Destabilize Its FMN Semiquinone.
Rwere F; Xia C; Im S; Haque MM; Stuehr DJ; Waskell L; Kim JJ
J Biol Chem; 2016 Jul; 291(28):14639-61. PubMed ID: 27189945
[TBL] [Abstract][Full Text] [Related]
20. P450BM-3; a tale of two domains--or is it three?
Peterson JA; Sevrioukova I; Truan G; Graham-Lorence SE
Steroids; 1997 Jan; 62(1):117-23. PubMed ID: 9029725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
